116 related articles for article (PubMed ID: 11810558)
1. Comparative uptake of grepafloxacin and ciprofloxacin by a human monocytic cell line, THP-1.
Hara T; Takemura H; Kanemitsu K; Yamamoto H; Shimada J
J Infect Chemother; 2000 Sep; 6(3):162-7. PubMed ID: 11810558
[TBL] [Abstract][Full Text] [Related]
2. Comparative uptake of sparfloxacin and ciprofloxacin into human THP 1 monocytic cells.
Rispal P; Grellet J; Celerier C; Breilh D; Dorian M; Pellegrin JL; Saux MC; Leng B
Arzneimittelforschung; 1996 Mar; 46(3):316-9. PubMed ID: 8901157
[TBL] [Abstract][Full Text] [Related]
3. Human THP-1 monocyte uptake and cellular disposition of 14C-grepafloxacin.
Hall IH; Schwab UE; Ward ES; Rublein JC; Butts JD; Ives TJ
J Infect Chemother; 2004 Feb; 10(1):11-8. PubMed ID: 14991512
[TBL] [Abstract][Full Text] [Related]
4. Uptake of fluoroquinolones in human monocytes isolated from peripheral blood.
Dorian M; Grellet J; Saux MC
J Pharm Pharmacol; 1998 Jul; 50(7):783-8. PubMed ID: 9720628
[TBL] [Abstract][Full Text] [Related]
5. Transport characteristics of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2.
Yamaguchi H; Yano I; Saito H; Inui K
Eur J Pharmacol; 2001 Nov; 431(3):297-303. PubMed ID: 11730721
[TBL] [Abstract][Full Text] [Related]
6. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
[TBL] [Abstract][Full Text] [Related]
7. Uptake of quinolones by in-vitro human monocyte derived macrophages.
Dorian M; Grellet J; Saux MC
J Pharm Pharmacol; 2001 May; 53(5):735-41. PubMed ID: 11370713
[TBL] [Abstract][Full Text] [Related]
8. Regulation of fluoroquinolone uptake by human neutrophils: involvement of mitogen-activated protein kinase.
Hotta K; Niwa M; Hirota M; Kanamori Y; Matsuno H; Kozawa O; Otsuka T; Matsui N; Uematsu T
J Antimicrob Chemother; 2002 Jun; 49(6):953-9. PubMed ID: 12039887
[TBL] [Abstract][Full Text] [Related]
9. Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration.
Patmore L; Fraser S; Mair D; Templeton A
Eur J Pharmacol; 2000 Oct; 406(3):449-52. PubMed ID: 11040352
[TBL] [Abstract][Full Text] [Related]
10. Comparison of antimycobacterial activity of grepafloxacin against Mycobacterium avium with that of levofloxacin: accumulation of grepafloxacin in human macrophages.
Hirota M; Totsu T; Adachi F; Kamikawa K; Watanabe J; Kanegasaki S; Nakata K
J Infect Chemother; 2001 Mar; 7(1):16-21. PubMed ID: 11406752
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone transport by human monocytes: characterization and comparison to other cells of myeloid lineage.
Bounds SJ; Nakkula R; Walters JD
Antimicrob Agents Chemother; 2000 Oct; 44(10):2609-14. PubMed ID: 10991832
[TBL] [Abstract][Full Text] [Related]
12. In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas.
Bébéar CM; Renaudin H; Schaeverbeke T; Leblanc F; Bébéar C
J Antimicrob Chemother; 1999 May; 43(5):711-4. PubMed ID: 10382895
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of grepafloxacin, ciprofloxacin, and theophylline in human plasma and urine by HPLC.
Kamberi M; Hajime N; Kamberi P; Uemura N; Nakamura K; Nakano S
Ther Drug Monit; 1999 Jun; 21(3):335-40. PubMed ID: 10365649
[TBL] [Abstract][Full Text] [Related]
14. Cotransport of macrolide and fluoroquinolones, a beneficial interaction reversing P-glycoprotein efflux.
Sikri V; Pal D; Jain R; Kalyani D; Mitra AK
Am J Ther; 2004; 11(6):433-42. PubMed ID: 15543082
[TBL] [Abstract][Full Text] [Related]
15. Contemporary re-evaluation of the activity and spectrum of grepafloxacin tested against isolates in the United States.
Gordon KA; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2003 Sep; 47(1):377-83. PubMed ID: 12967754
[TBL] [Abstract][Full Text] [Related]
16. Determining the frequency of resistance of Streptococcus pneumoniae to ciprofloxacin, levofloxacin, trovafloxacin, grepafloxacin, and gemifloxacin.
Evans ME
Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):883-5. PubMed ID: 11837640
[TBL] [Abstract][Full Text] [Related]
17. Determination of lipophilicity of two quinolone antibacterials, ciprofloxacin and grepafloxacin, in the protonation equilibrium.
Sun J; Sakai S; Tauchi Y; Deguchi Y; Chen J; Zhang R; Morimoto K
Eur J Pharm Biopharm; 2002 Jul; 54(1):51-8. PubMed ID: 12084502
[TBL] [Abstract][Full Text] [Related]
18. The comparative arthropathy of fluoroquinolones in dogs.
Takizawa T; Hashimoto K; Minami T; Yamashita S; Owen K
Hum Exp Toxicol; 1999 Jun; 18(6):392-9. PubMed ID: 10413244
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Barry AL; Fuchs PC
J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
[TBL] [Abstract][Full Text] [Related]
20. Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells.
Lowes S; Simmons NL
Br J Pharmacol; 2002 Mar; 135(5):1263-75. PubMed ID: 11877335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
